CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Big Upside Potential

By HEFFX Australia on June 12, 2020   2020, Coronavirus, Headline News, Health, Heffx Insights, Investments, MetaStock, Opinion, Shayne Heffernan, Shayne Heffernan, Stocks, Strategy, Todays Trade Ideas, Top Stories, US Stocks  

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Big Upside Potential CymaBay TherapeuticsTicker: CymaBay TherapeuticsPrice: $3.39 Business Summary CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. Its pipeline includes Seladelpar, MBX-2982 and CB-001. The Company’s lead product candidate, seladelpar, is a potent […]